Participant Duties Sample Clauses

Participant Duties. The Participant: (a) acknowledges that they: (i) are physically fit and healthy, (ii) have trained for the Event; and (iii) has reviewed the course description(s) of the Event, (b) acknowledges that there is risk of serious injury, illness, and in extreme cases, loss of life, from various causes including but not limited to dehydration, hypothermia, hyperthermia, accidents with other participants, or heart attack, and (to the greatest extent permitted by law) Participant accepts all risks involved (also including by way of example only, Participant's own abilities or equipment, road or track surfaces, weather, pedestrians, spectators) and agrees to participate in the Event at their own risk; (c) releases Total Sport (including their officers, sponsors, agents, contractors, volunteers and employees) to the maximum extent permitted by law from all liability for any loss (direct or indirect loss), injury or death (including liability for negligence and/or recklessness) arising out of or in connection with Participant's intended or actual participation in an Event; (d) acknowledges that Total Sport's safety briefings, event officials, signs, and directions are part of the services, but are not, and will not be, a guarantee of safety; (e) will, or has, read the Event safety rules and will attend any Event safety briefing in relation to the Event; (f) will comply with all rules and directions of Event officials and their personnel (including contractors, employees, and volunteers) and acknowledges that this compliance is important to ensure the safety of all participants of the Event; (g) agrees to disclose to, and will notify Total Sport of, any personal medical conditions which may affect themselves, staff, or other participants at a Total Sport event, consents to receiving any necessary medical treatment from the Event medical staff, and agrees to disclose relevant medical information when being treated by a Total Sport staff member or Event medic during an Event; (h) acknowledges that Total Sport will not be responsible for the security of any personal belongings at the Event; (i) confirms they are 18 years of age or over, and where the Participant is below the age of 18, the Participant agrees to have this Agreement viewed, signed, or otherwise agreed by their guardian, and guardians of children confirm the Participant is fit to enter and complete the Event (and otherwise confirms and acknowledges on behalf of the child where required under this Agreement);...
AutoNDA by SimpleDocs
Participant Duties. The duties of the Participants under this Agreement are to: 3.3.1 Make timely payment of all Project Costs. 3.3.2 The Participants hereby agree to conduct all necessary work, secure all necessary authorities, transmit all necessary forms, and to work collaboratively to complete all activities in a timely manner. 3.3.3 Upon execution of this Agreement, each Participant shall identify a Designated Representative who will represent that Participant as part of an ad hoc committee. The ad hoc committee shall be responsible for reviewing the information developed by NCPA staff to achieve the purposes of this Agreement. A Participant may change the designation of its Designated Representative at any time upon providing written confirmation to NCPA.
Participant Duties. The duties of the Participants under this Agreement are to: 4.1 Provide Participant load, resource, trade, ancillary services, and/or other CAISO product schedules and bids to NCPA, as applicable, in accordance with Appendix C, where the Participant shall act as an Operating Entity or NCPA shall act as an Operating Entity on behalf of a Participant or group of Participants, subject to separate agreement, upon which NCPA using such information will submit schedules and bids to the CAISO as Scheduling Coordinator or Scheduling Agent for the Participants. 4.2 Make timely payments to NCPA for all CAISO charges and credits for services invoiced by NCPA to the Participant in accordance with Section 6 of this Agreement. 4.3 Provide staff and other assistance as may be required from time to time to the extent necessary for NCPA to fulfill its duties as described in Section 3 of this Agreement. 4.4 Comply with all requirements of the MSSA Agreement and CAISO Tariff, as applicable, in respect to the operation and maintenance of its Electric System and other facilities covered under this Agreement. 4.5 Provide security or other deposits required by the CAISO to NCPA in accordance with Section 9 of this Agreement. 4.6 Initially fund and maintain sufficient deposits in its Balancing Account in accordance with Section 10 of this Agreement. 4.7 Provide NCPA access to settlement quality meter data from loads and resources scheduled and bid by NCPA for a Participant under this Agreement, and to maintain such meters and metering equipment in accordance with the standards and requirements set forth in the MSSA Agreement, CAISO Tariff and Appendix F of this Agreement, unless otherwise agreed to between NCPA and the Participant. 4.8 Make timely payment of all costs associated with NCPA’s provision of Scheduling Coordination Services, including, but not limited to, Administrative Services Costs, allocated among the Participants in accordance with this Agreement and the Power Management and Administrative Services Agreement. 4.9 Indemnify NCPA in regard to Scheduling Coordination Services provided to a Participant by NCPA.
Participant Duties. Subject to the terms hereof, Participant shall: (i) provide reasonable promotional support for the Cartel Xxxx; (ii) comply with any and all of the terms of the Operating Procedures Manual; and (iii) with respect to any and all proper third parties, designate IDT as Participant's Primary Network.
Participant Duties 

Related to Participant Duties

  • Plan Administrator Duties The Plan Administrator shall administer this Agreement according to its express terms and shall also have the discretion and authority to (i) make, amend, interpret and enforce all appropriate rules and regulations for the administration of this Agreement and (ii) decide or resolve any and all questions, including interpretations of this Agreement, as may arise in connection with this Agreement to the extent the exercise of such discretion and authority does not conflict with Code Section 409A.

  • Employee Duties The Employee agrees that they will act in accordance with this Agreement and with the best interests of the Employer in mind, which may or may not require them to present the best of their skills, experience, and talents, to perform all the duties required of the position. In carrying out the duties and responsibilities of their position, the Employee agrees to adhere to any and all policies, procedures, rules, regulations, as administered by the Employer. In addition, the Employee agrees to abide by all local, county, State, and Federal laws while employed by the Employer.

  • Administrator Duties The Administrator has a duty to perform or observe all tasks to be performed or observed by the Administrator contained in this Agreement or otherwise.

  • Participant Contributions If Participant contributions are permitted, complete (a), (b), and (c). Otherwise complete (d).

  • Participant Responsibilities You must tell the study investigator if you previously took part in this study, have been in any other study in the past year, or are currently involved in any other study. This includes being in the follow-up visit period of another study • You must agree to the scheduled visits, the study plan, lab tests, study procedures, and diet and activity restrictions (details listed later in this document) • You must not have any significant medical or psychiatric condition, as determined by the study investigator, that may put your safety at risk or could have an effect on the study results • Optional Japanese participants must have 4 Japanese biological grandparents who were born in Japan • You must weigh more than 110 lb (99 lb if a Japanese participant) • Your body mass index (BMI) must be between: o Part A, B, and C – 20 -33 kg/m2 o Japanese participants – 16 – 33 kg/m2 • You may be asked to provide documentation of your childbearing status • You must not have a history of phototoxicity or photosensitivity • You must not have a current or past diagnosis of type 1 or type 2 diabetes mellitus • You must not take any medications (including over-the-counter medications, such as medications for cold or allergies, antacids, herbal supplements, minerals, or vitamins) within 7 days before the first dose or at any time during the study o You must not take hormone replacement therapy (HRT) within 28 days before the first dose or at any time during the study ▪ Depo-Provera® must be discontinued at least 6 months before the first dose o Before taking any drugs other than the study drugs, you must call the CRU for approval. It must first be approved by the study investigator o You must tell the study staff about any drugs taken during the study • You must not have taken any medications, dietary or herbal supplements that are inhibitors or inducers of certain enzymes or proteins within 14 days or 5 half-lives (which is drug dependent); before the first dose or at any time during the study o The study investigator or study staff will review a list of these medications and substances with you • You must not take any investigational product (drug or vaccine) within 30 days before the first dose of this study • You must not have a history of sensitivity reactions to midazolam or any of the components of the liquid formulation • You may only participate in one part of this study • You must not have donated blood for at least 60 days before dosing. Plasma (a component of blood) donation may be allowed o You cannot donate any blood or blood products at any time during this study. Donation is not allowed for at least 4 weeks after your last blood draw • You must not have a history of excessive alcohol use or binge drinking and/or other illicit drug use within 6 months before screening o Binge drinking is defined as a pattern of 5 (male) or 4 (female) or more alcoholic drinks in about 2 hours o You should not drink more than 14 alcoholic drinks a week o A drink is defined as 8 oz. (1 cup) of beer, 3 oz. (6 tablespoons) of wine, or 1 oz. (2 tablespoons) of hard liquor • You must not be using/taking any drugs of abuse (such as marijuana, cocaine, opioids, etc.). Urine tests will be done to check for such drugs. o If a test is positive, you will not be allowed in the study o Urine collection may be monitored by a staff member of the same sex o You have the right to refuse to be monitored, but may be disqualified from the study o While in this study, please do not eat anything that contains poppy seeds. They may cause a positive drug test • You must not use tobacco or nicotine-containing products in excess of the equivalent of 5 cigarettes or 2 chews of tobacco per day • You must not use tobacco- or nicotine-containing products for 24 hours before the first dose and while confined to the CRU • Please let us know if you or a relative are a staff member of Pfizer. If so, you may not take part in this study if you or your relative are supervised by the study investigator or are directly involved with the study • You will need to stay in the CRU for up to 12 days (Part A) starting with each check-in o Japanese participants will need to stay in the CRU for 12 days starting with check-in o Participants in Group 4 will need to stay in the CRU for 26 days starting with check-in • You will need to stay in the CRU for 19 days (Part B) • You will need to stay in the CRU for 13 days (Part C) • All participants: you may need to stay in the CRU for longer if you experience a longer study drug effect. This is for safety reasons o The study investigator or study staff will decide when it is safe for you to leave the CRU • You must not do any strenuous exercise for at least 48 hours before each blood draw for safety labs. Examples of this include heavy lifting, weight training, or aerobics o Walking at a normal pace is allowed • You may be asked to wear a device (similar to a wristwatch) that can be used to alert study staff in case of an emergency • You will be confined to the procedure room for the first 4 hours during each continuous cardiac monitoring, except to use the bathroom (Part A only) • You cannot lie down for 4 hours after dosing on days when blood samples for study drug levels are collected, unless needed for study procedures • You are advised to avoid direct sunlight or any high intensity UV light exposure from your first admission to the CRU through your last follow-up contact with the CRU o You should apply sunscreen with a sun protection factor (SPF) of greater than or equal to 50 and wear eye-protective sunglasses • You must not eat or drink anything except water for at least 10 hours before each safety laboratory test • You must not eat or drink anything except water for at least 10 hours before collection of the pre- dose blood sample for study drug and other pre-dose blood samples o Except for 1 hour before and 1 hour after dosing (Part A only), you may drink water freely o You can drink water freely if you are in Part B or C • If dosing under fasting conditions (Part A), you must not eat or drink anything (except water) for at least 10 hours before dosing • If dosing under fed conditions (Part A), you must not eat or drink anything except water for at least 10 hours before eating breakfast • If dosing when an OGTT will be done (Parts A and B), you must not eat or drink anything (except water) for at least 10 hours before dosing and/or OGTT • If dosing with a standard breakfast (Part B and C), you must not eat or drink anything (except water) for at least 10 hours before eating breakfast • You must not drink red wine for 7 days before the first dose. Red wine is not allowed through the collection of the last blood sample for study drug • You must not eat or drink anything with alcohol for 24 hours (or as stated above for red wine) before (each) check-in. Alcohol is not allowed through the collection of the last blood sample for study drug in each period o Study staff may check your breath for alcohol. If alcohol is found, you will not be allowed in the study • You must not eat or drink anything with caffeine for 24 hours before dosing. Caffeine is not allowed through the collection of the last blood sample for study drug in each period o Caffeine can be found in different foods and drinks. Some examples include chocolate, coffee, tea, cola, Xx. Xxxxxx®, and Mountain Dew® • You must not eat or drink anything that has grapefruit or grapefruit-related citrus fruits for 7 days before the first dose. These are not allowed through collection of the last blood sample for study drug o Examples of citrus fruits that are not allowed are Seville oranges and pomelos o Fruit juices and smoothies may also contain grapefruit or these citrus fruits • Lunch will be provided about 4–5 hours after dosing • Dinner will be provided about 9-10 hours after dosing • An evening snack may be allowed about 12-13 hours after dosing • If it is necessary to split doses and dose twice a day, the timing of meals or snacks may be changed during • Meals (breakfast, lunch, dinner, and evening snacks) will be provided at appropriate times on all other study days o On non-dosing days while in the CRU, meals and evening snacks will be provided at about the same time as when given on dosing days This study is for research purposes only. There may be no direct benefit to you from taking part. However, information learned from this study may benefit other people in the future. This study is for research purposes only. Your alternative is to not take part in the study.

  • Administrative Duties 94 SECTION 12.2 Records.....................................................................97 SECTION 12.3 Additional Information to be Furnished to the Issuer........................97

  • Personnel Participant Conditions The Subrecipient shall include the following clauses in every Subcontract or purchase order, specifically or by reference, so that such provisions will be binding upon each subcontractor or vendor.

  • Sharing of Participant Information 20 7.4 REPORTING AND DISCLOSURE AND COMMUNICATIONS TO PARTICIPANTS..................................................20 7.5 NON-TERMINATION OF EMPLOYMENT; NO THIRD-PARTY BENEFICIARIES.................................................20 7.6

  • Participant Loans Participant loans, as provided for in paragraph 13.5 of the Basic Plan Document #04, [x] are [ ] are not permitted. If permitted, repayments of principal and interest shall be repaid to [x] the Participant's segregated account or [ ] the general Fund.

  • Participant Information My address is: My Social Security Number is:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!